Ngā hua rapu - Philippe Caron

Whakamahine hua
  1. 1
    Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management

    Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management mā Philippe Caron

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Thyroiditis and SARS-CoV-2 pandemic: a review

    Thyroiditis and SARS-CoV-2 pandemic: a review mā Philippe Caron

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management

    Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management mā Philippe Caron

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Covid-19, the thyroid and the pituitary — The real state of play

    Covid-19, the thyroid and the pituitary — The real state of play mā Aurore Geslot, Philippe Chanson, Philippe Caron

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide<sup>1</sup>

    Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide<sup>1</sup> mā Philippe Caron, I. Morange‐Ramos, Muriel Cogne, P Jaquet

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Primary Pigmented Nodular Adrenocortical Disease: Paradoxical Responses of Cortisol Secretion to Dexamethasone Occur in Vitro and Are Associated with Increased Expression of the Glucocorticoid Receptor

    Primary Pigmented Nodular Adrenocortical Disease: Paradoxical Responses of Cortisol Secretion to Dexamethasone Occur in Vitro and Are Associated with Increased Expression of the Gl... mā Isabelle Bourdeau, André Lacroix, Walter Schürch, Philippe Caron, Tony Antakly, Constantine A. Stratakis

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Somatostatin analogs: does pharmacology impact antitumor efficacy?

    Somatostatin analogs: does pharmacology impact antitumor efficacy? mā Mounira Chalabi, Camille Duluc, Philippe Caron, Delphine Vezzosi, Julie Guillermet‐Guibert, Stéphane Pyronnet, Corinne Bousquet

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Acromegaly and Pregnancy: A Retrospective Multicenter Study of 59 Pregnancies in 46 Women

    Acromegaly and Pregnancy: A Retrospective Multicenter Study of 59 Pregnancies in 46 Women mā Philippe Caron, S. Broussaud, Jérôme Bertherat, Françoise Borson‐Chazot, Thierry Brue, Christine Cortet‐Rudelli, Philippe Chanson

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial

    Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial mā Philippe Caron, John S. Bevan, Stephan Petersenn, Daniel Flanagan, Antoine Tabarin, Gaëtan Prévost, Pascal Maisonobe, Antoine Clermont

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Current Scientific Rationale for the Use of Somatostatin Analogs and mTOR Inhibitors in Neuroendocrine Tumor Therapy

    Current Scientific Rationale for the Use of Somatostatin Analogs and mTOR Inhibitors in Neuroendocrine Tumor Therapy mā Corinne Bousquet, Charline Lasfargues, Mounira Chalabi, Siham Moatassim Billah, Christiane Susini, Delphine Vezzosi, Philippe Caron, Stéphane Pyronnet

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Paraganglioma after Maternal Transmission of a Succinate Dehydrogenase Gene Mutation

    Paraganglioma after Maternal Transmission of a Succinate Dehydrogenase Gene Mutation mā Pascal Pigny, Audrey Vincent, Catherine Bauters, Monelle Bertrand, Vincent de Montpréville, Michel Crépin, Nicole Porchet, Philippe Caron

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Effects of Thyroid-Stimulating Hormone Suppression with Levothyroxine in Reducing the Volume of Solitary Thyroid Nodules and Improving Extranodular Nonpalpable Changes: A Randomized, Double-Blind, Placebo-Controlled Trial by the French Thyroid Research Group

    Effects of Thyroid-Stimulating Hormone Suppression with Levothyroxine in Reducing the Volume of Solitary Thyroid Nodules and Improving Extranodular Nonpalpable Changes: A Randomize... mā Jean-Louis Wémeau, Philippe Caron, Claire Schvartz, Jean-Louis Schlienger, Jacques Orgiazzi, C. Cousty, Virginie Vlaeminck‐Guillem

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Long‐term (up to 18 years) effects on GH/IGF‐1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH‐secreting pituitary adenoma responsive to SSTa

    Long‐term (up to 18 years) effects on GH/IGF‐1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH‐secreting pituitary adenoma respon... mā Jean Christophe Maiza, Delphine Vezzosi, Maria Matta, F. Donadille, F. Loubes-Lacroix, Maxime Cournot, Antoine Bennet, Philippe Caron

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Resistance of Hypogonadic Patients with Mutated GnRH Receptor Genes to Pulsatile GnRH Administration

    Resistance of Hypogonadic Patients with Mutated GnRH Receptor Genes to Pulsatile GnRH Administration mā Philippe Caron, Stéphanie Chauvin, Sophie Christin‐Maître, Antoine Bennet, Najiba Lahlou, Raymond Counis, Philippe Bouchard, Marie‐Laure Kottler

    I whakaputaina 1999
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone

    Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone mā Aart‐Jan van der Lely, Ignacio Bernabéu, Cáp J, Philippe Caron, Annamaria Colao, J Marek, Sebastian Neggers, P Birman

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Efficacy of the Long-Acting Octreotide Formulation (Octreotide-Lar) in Patients with Thyrotropin-Secreting Pituitary Adenomas

    Efficacy of the Long-Acting Octreotide Formulation (Octreotide-Lar) in Patients with Thyrotropin-Secreting Pituitary Adenomas mā Philippe Caron, S Arlot, Catherine Bauters, Philippe Chanson, Jean‐Marc Kuhn, Michel Pugeat, R. Maréchaud, Céline Teutsch, Elisabeth Vidal, P Sassano

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors

    Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors mā Delphine Vezzosi, Dorthe Cartier, C Régnier, P. Otal, Anna M. Bennet, F Parmentier, Monique Plantavid, André Lacroix, Hervé Lefèbvre, Philippe Caron

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study

    Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study mā Philippe Caron, Thierry Brue, Gérald Raverot, Antoine Tabarin, Anne Cailleux, Brigitte Delemer, Peggy Pierre Renoult, Aude Houchard, Fatine Elaraki, Philippe Chanson

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves’ Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study

    Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves’ Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study mā J.-L. Wémeau, Philippe Caron, Albert Beckers, V. Rohmer, Jacques Orgiazzi, Françoise Borson‐Chazot, M Nocaudie, Petros Perimenis, Ségolène Bisot-Locard, I. Bourdeix, S. Dejager

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Interest of Routine Measurement of Serum Calcitonin: Study in a Large Series of Thyroidectomized Patients

    Interest of Routine Measurement of Serum Calcitonin: Study in a Large Series of Thyroidectomized Patients mā Patricia Niccoli, N. Wion-Barbot, Philippe Caron, Jean‐François Henry, Cathérine De Micco, Jean-Pierre Saint Andre, Jean‐Claude Bigorgne, E Modigliani, B. Conte‐Devolx

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: